Peramivir Inhalation Solution (Langtian Medical Tech)

帕拉米韦吸入溶液 (朗天医药科技)

Report date: 2026/05/13 20:02:10

Base Information

Drug NamePeramivir Inhalation Solution (Langtian Medical Tech)
Drug Alias Name帕拉米韦吸入溶液 (2.2类改良型)
ClassificationSmall molecules
Mechanisms of ActionNeuraminidase inhibitors
TargetsNeuraminidase
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza B virus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesLangtian Medical Technology (Wuhan) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLangtian Medical Technology (Wuhan) Co LtdLodays Pharmaceutical(Hubei) Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsInfluenza B virus infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A